Investigators: Fiona McDonald, Jan Jones, Jennifer Kent, Peter Richmond, Tanya Stoney
Project description
The purpose of this study is to determine if we should give toddlers aged 12 to 14 months of age 1 or 2 doses of the Nimenrix™ vaccine, which is intended to protect against meningococcal disease cause by the subgroups A, C, W-135 and Y. We are also assessing if the Nimenrix™ vaccine can be given at the same time as the pneumococcal vaccine called Prevenar 13™.
Partners:
- GSK